Synthomer (SYNT) Q3 2025 TU earnings summary

Executive summary

• Q3 2025 performance remained resilient despite ongoing soft demand in several end markets, with Adhesive Solutions leading recovery and margin improvement.

• Additional cost-saving and efficiency initiatives helped offset subdued market conditions, including a global workforce reduction of around 250 roles.

• Strategic transformation and divestment efforts continued, with a focus on deleveraging and portfolio simplification.

Financial highlights

• Continuing Group EBITDA for 2025 is expected to be similar to the £143m reported in 2024.

• Anticipated cash inflow in H2 2025 is expected to result in broadly neutral Free Cash Flow for the year.

Outlook and guidance

• Persistently soft end-market demand is expected for the remainder of 2025, but self-help actions are expected to largely mitigate the impact.

• Full-year 2026 earnings and cash generation are anticipated to improve due to ongoing cost actions and product investments.

• Medium-term objective remains to double recent earnings levels through cost actions and a focus on specialty products.